Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Takeuchi

Showing results (1-10 of 785) with videos related to

Pageof 79
Sort By:
Inflammation and Regeneration|December 28, 2022
Correction: Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases-RA as a role modelTsutomu Takeuchi
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 13, 2017
Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory diseaseTsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Guidelines for usage of biological agents for treatment of rheumatoid arthritis]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Biological agents for therapy of rheumatoid arthritis--overview]Tsutomu Takeuchi
Seminars in Arthritis and Rheumatism|April 3, 2025
New anti-TNF biologics in RA: What is new and what is old?Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 13, 2003
[Physiopathology and molecular mechanism involving systemic lupus erythematosus]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2003
[Protozoan diseases--overview]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 14, 2006
[TNF targetting therapy for rheumatoid arthritis]Tsutomu Takeuchi
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|January 12, 2018
Addendum to "Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease"Tsutomu Takeuchi
Arerugi = [Allergy]|February 3, 2007
[Recent progress of biological agents in collagen-vasucular diseases]Tsutomu Takeuchi
Pageof 79

Showing results (1-10 of 785) with videos related to

Sort By:
Pageof 79
Inflammation and Regeneration|December 28, 2022
Correction: Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases-RA as a role modelTsutomu Takeuchi
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 13, 2017
Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory diseaseTsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Guidelines for usage of biological agents for treatment of rheumatoid arthritis]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Biological agents for therapy of rheumatoid arthritis--overview]Tsutomu Takeuchi
Seminars in Arthritis and Rheumatism|April 3, 2025
New anti-TNF biologics in RA: What is new and what is old?Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 13, 2003
[Physiopathology and molecular mechanism involving systemic lupus erythematosus]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2003
[Protozoan diseases--overview]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 14, 2006
[TNF targetting therapy for rheumatoid arthritis]Tsutomu Takeuchi
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|January 12, 2018
Addendum to "Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease"Tsutomu Takeuchi
Arerugi = [Allergy]|February 3, 2007
[Recent progress of biological agents in collagen-vasucular diseases]Tsutomu Takeuchi
Pageof 79